What is biologic and biosimilar?
Biosimilars are the non-branded versions of the original biologic. Original reference biologics are usually more expensive because of the high cost of researching and manufacturing them, therefore biosimilars can be marketed once the patent on the original biologic has expired.
Biosimilars are comparable in terms of quality, safety and efficacy to their version of an approved original biologics but are more affordable.
Both biologics and biosimilars are one kind of disease-modifying anti-rheumatic drugs (called “DMARDs”). They reduce uncontrolled immune processes and inflammation in your joints, skin, muscles and gut. This improves symptoms, reduces flares, stops disease progression and improves quality of life.
The term "biologic" or "biosimilar" simply means the medications are derived from animal or human proteins and not from chemicals (like other medications). They are highly effective medications that have been used for years.
Common Examples of Biologics |
||||||||
TNF-alpha blocker |
IL-1 blocker |
IL-6 blocker |
IL-17 blocker |
IL- 23 blocker | IL-12/23 blocker |
B-cell blocker |
T-cell blocker |
Integrin receptor blocker |
Adalimumab Certolizumab Etanercept Golimumab Infliximab |
Anakinra Canakinumab Rilonacept |
Tocilizumab |
Ixekizumab Secukinumab |
Guselkumab Risankizumab |
Ustekinumab |
Belimumab Rituximab |
Abatacept |
Vedolizumab |
• Ankylosing spondylitis (AS)
• Inflammatory bowel disease (IBD) such as Crohn’s Disease (CD) and Ulcerative Colitis (UC)
• Juvenile (children) arthritis
• Multiple sclerosis (MS)
• Psoriasis
• Psoriatic arthritis (PsA)
• Rheumatoid arthritis (RA)
• Scleroderma
Biologics and biosimilars are given by subcutaneous injection (injected into fat tissue under the skin) or intravenous infusion (injected directly into a vein) because the proteins can be damaged by stomach acid if given by mouth. Infusions will require administration by a healthcare professional while self-injection can be performed by patient or caregiver at home.
Side effects for biologics and biosimilars |
||
Common > 10% Infection such as cold, upper respiratory infection, sinusitis Mild injection site reactions such as redness and pain |
Uncommon 1-3% Severe infection require hospitalisation Severe infusion reactions |
Rare < 1 in 1000 Tuberculosis (TB) Shingles Hepatitis B Cancer of the blood, skin or lung Immune diseases such as lupus-like syndrome |
Disclaimers
If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (National Healthcare Group, National University Health System, and SingHealth), community pharmacies (Guardian, Unity, and Watsons), and the Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Last Updated on October 2022
Use Medicine Order Service on HealthBuddy.
Get reminders and chart progress on HealthBuddy.